11/12/2025 16:05
UBS lowered the target price for Giant Biogene (02367) to HKD39.5 from HKD79.5 and downgraded the rating to "neutral" from "buy".
The research house said it is turning more cautious about the near-term sales growth outlook and expects Giant Biogene's sales growth to decelerate to 5% during 2026-28.
【你點睇？】港交所推每周股票期權新選擇，若能新增一隻作每周股票期權標的，您會選擇哪一隻？► 立即讚好
上一篇新聞︰12/12/2025 14:40 {I-bank focus}Morgan raises COSCO Ship Hold to HKD10.3
下一篇新聞︰11/12/2025 14:32 {I-bank focus}J.P. Morgan lowers Brilliance Chi to HKD4.1
15/12/2025 16:00 {I-bank focus}Citi raises Li Ning (02331) to HKD20.6
15/12/2025 14:35 {I-bank focus}Morgan raises Ali Health (00241) to HKD4.6
12/12/2025 16:08 {I-bank focus}Citi lowers China Res Power (00836) to HKD19
09/12/2025 16:02 {I-bank focus}Citi lowers HKEX (00388) to HKD505
09/12/2025 15:10 {I-bank focus}Citi raises Brilliance Chi (01114) to HKD4.8
